Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days

Archives of Toxicology

Volumn 89, Issue 9, 2015, Pages 1569-1578

  Yan, Shengmin ^a   Wang, Jianshe ^a   Dai, Jiayin ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

Lipid metabolism; Perfluorononanoic acid; PPAR; SREBP

Indexed keywords

CHOLESTEROL; MESSENGER RNA; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN; FLUOROCARBON; MICRORNA; MIRN182 MICRORNA, MOUSE; MIRN183 MICRORNA, MOUSE; MIRN96 MICRORNA, MOUSE; OCTANOIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY ACID METABOLISM; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HEPATOMEGALY; IN VITRO STUDY; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; TIME FACTOR; TUMOR CELL LINE;

ANIMALS; CAPRYLATES; CELL LINE, TUMOR; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROCARBONS; GENE EXPRESSION REGULATION; LIVER; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; PPAR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEINS; TIME FACTORS;

EID: 84940611926     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1322-7     Document Type: Article

References (35)

1. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233
2. Bengoechea-Alonso MT, Ericsson J (2007) SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol 19(2):215–222
3. Bjork JA, Butenhoff JL, Wallace KB (2011) Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology 288(1–3):8–17
4. Dumortier O, Hinault C, Van Obberghen E (2013) MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 18(3):312–324
5. Fang X, Zou S, Zhao Y et al (2012) Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor alpha expression by releasing cytokines. Arch Toxicol 86(10):1515–1525
6. Fernandez-Alvarez A, Alvarez MS, Gonzalez R, Cucarella C, Muntane J, Casado M (2011) Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 286(24):21466–21477
7. Gao M, Bu L, Ma Y, Liu D (2013) Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice. PLoS ONE 8(6):e65641
8. Haughom B, Spydevold O (1992) The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim Biophys Acta 1128(1):65–72
9. Horton JD (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc T 30:1091–1095
10. Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109(9):1125–1131
11. Jeon TI, Osborne TF (2012) SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23(2):65–72
12. Jeon TI, Esquejo RM, Roqueta-Rivera M et al (2013) An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab 18(1):51–61
13. Kennedy GL Jr, Butenhoff JL, Olsen GW et al (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34(4):351–384
14. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405(6785):421–424
15. Knight BL, Hebbachi A, Hauton D et al (2005) A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver. Biochem J 389(Pt 2):413–421
16. Konig B, Koch A, Spielmann J et al (2009) Activation of PPAR alpha and PPAR gamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1. Eur J Pharmacol 605(1–3):23–30
17. Kudo N, Mizuguchi H, Yamamoto A, Kawashima Y (1999) Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver. Chem Biol Interact 118(1):69–83
18. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99(2):366–394
19. Matsuda M, Korn BS, Hammer RE et al (2001) SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Gene Dev 15(10):1206–1216
20. Minata M, Harada KH, Karrman A et al (2010) Role of peroxisome proliferator-activated receptor-alpha in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver. Ind Health 48(1):96–107
21. Osborne TF (2001) CREating a SCAP-less liver keeps SREBPs pinned in the ER membrane and prevents increased lipid synthesis in response to low cholesterol and high insulin. Gene Dev 15(15):1873–1878
22. Pyper SR, Viswakarma N, Yu S, Reddy JK (2010) PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal 8:e002
23. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB (2008) SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19(2):65–73
24. Rosen MB, Abbott BD, Wolf DC et al (2008a) Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid. Toxicol Pathol 36(4):592–607
25. Rosen MB, Lee JS, Ren H et al (2008b) Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol Sci 103(1):46–56
26. Rosen MB, Schmid JR, Corton JC, et al. (2010) Gene Expression Profiling in Wild-Type and PPARalpha-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARalpha-Independent Effects. PPAR Res 2010, 794739
27. Scharmach E, Buhrke T, Lichtenstein D, Lampen A (2012) Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4alpha). Toxicol Lett 212(2):106–112
28. Shao W, Espenshade PJ (2012) Expanding roles for SREBP in metabolism. Cell Metab 16(4):414–419
29. Takacs ML, Abbott BD (2007) Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci 95(1):108–117
30. Tan X, Xie G, Sun X et al (2013) High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways. PLoS ONE 8(4):e61409
31. Varga T, Czimmerer Z, Nagy L (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 1812(8):1007–1022
32. Wan HT, Zhao YG, Wei X, Hui KY, Giesy JP, Wong CK (2012) PFOS-induced hepatic steatosis, the mechanistic actions on beta-oxidation and lipid transport. Biochim Biophys Acta 1820(7):1092–1101
33. Wolf DC, Moore T, Abbott BD et al (2008) Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice. Toxicol Pathol 36(4):632–639
34. Yan S, Wang J, Zhang W, Dai J (2014) Circulating MicroRNA profiles altered in mice after 28 days exposure to perfluorooctanoic acid. Toxicol Lett 224(1):24–31
35. Yoshikawa T, Ide T, Shimano H et al (2003) Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol Endocrinol 17(7):1240–1254